Thus, as already applied for mitochondrial diseases [57], we propose NDI1 as a useful tool to uncover NADH dehydrogenase inhibition in specific tumor cells and bypass it in order to assess its potential contribution to neoplastic transformation. Here, AVPR2 is linked to neoplasm.